During the last session, Zura Bio Ltd (NASDAQ:ZURA)’s traded shares were 0.55 million, with the beta value of the company hitting 0.20. At the end of the trading day, the stock’s price was $3.39, reflecting an intraday loss of -4.24% or -$0.15. The 52-week high for the ZURA share is $7.63, that puts it down -125.07 from that peak though still a striking 41.0% gain since the share price plummeted to a 52-week low of $2.00. The company’s market capitalization is $216.35M, and the average intraday trading volume over the past 10 days was 0.36 million shares, and the average trade volume was 282.43K shares over the past three months.
Zura Bio Ltd (ZURA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ZURA has a Sell rating from 0 analyst(s) out of 11 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 8 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zura Bio Ltd (NASDAQ:ZURA) trade information
Zura Bio Ltd (ZURA) registered a -4.24% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.24% in intraday trading to $3.39, hitting a weekly high. The stock’s 5-day price performance is -6.87%, and it has moved by -14.18% in 30 days. Based on these gigs, the overall price performance for the year is -49.40%. The short interest in Zura Bio Ltd (NASDAQ:ZURA) is 1.79 million shares and it means that shorts have 6.37 day(s) to cover.
Zura Bio Ltd (ZURA) estimates and forecasts
Statistics show that Zura Bio Ltd has outperformed its competitors in share price, compared to the industry in which it operates. Zura Bio Ltd (ZURA) shares have gone down -13.52% during the last six months, with a year-to-date growth rate more than the industry average at 74.64% against 16.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 88.50% this quarter and then jump 16.70% in the quarter after that.
While earnings are projected to return 75.02% in 2024.
ZURA Dividends
Zura Bio Ltd is due to release its next quarterly earnings 2024-Aug-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
Zura Bio Ltd insiders own 39.05% of total outstanding shares while institutional holders control 52.81%, with the float percentage being 86.65%.
Also, the Mutual Funds coming in first place with the largest holdings of Zura Bio Ltd (ZURA) shares are Vanguard Extended Market Index Fund and iShares Russell 2000 ETF . Data provided on Mar 31, 2024 indicates that Vanguard Extended Market Index Fund owns about 483.3 shares. This amounts to just over 0.76 percent of the company’s overall shares, with a $1.64 million market value. The same data shows that the other fund manager holds slightly less at 447.2, or about 0.70% of the stock, which is worth about $1.52 million.
